Tilray Brands, Inc. to Announce First Quarter 2024 Financial Results on October 4, 2023
NEW YORK and LEAMINGTON, Ontario, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced that the Company will release financial results for its first quarter ended August 31, 2023 on October 4, 2023.
Live Audio Webcast
Tilray will host a live audio webcast to discuss these results at 8:30 am Eastern Time, which can be accessed on the Investors section of Tilray's website at www.Tilray.com. A replay will be available and archived on the Company’s website.
Retail Investor Q&A
Tilray Brands stockholders can submit and upvote questions via the stockholder Q&A platform Say Technologies beginning today and until October 3, 2023. To submit questions ahead of the webcast, please visit the Say Technologies platform at https://app.saytechnologies.com/tilray-brands-2024-q1
About Tilray Brands
Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), is a leading global cannabis lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people's lives for the better – one person at a time – by inspiring and empowering a worldwide community to live their very best life, enhanced by moments of connection and wellbeing. Tilray’s mission is to be the most responsible, trusted, and market-leading cannabis and consumer products company in the world with a portfolio of innovative, high-quality, and beloved brands that address the needs of the consumers, customers, and patients we serve. A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.
For more information on how we open a world of well-being, visit www.Tilray.com and follow @tilray on all social platforms.
For further information:
Media: Berrin Noorata, firstname.lastname@example.org
Investors: Raphael Gross, (203) 682-8253, Raphael.Gross@icrinc.com
Upcoming Life Sciences Events
- December 2023
- Pharma-Biotech Product & Company Valuation with Dr. P Frei
- Leiden: Dutch Life Sciences Conference
- London: Genesis 2023